Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus

Relevance. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies.The aim of the study – to compare composition of peripheral blood cytotoxic CD8+ T lymphocytes (Tc) subsets and assess the clinical significance...

Full description

Saved in:
Bibliographic Details
Main Authors: S. S. Benevolenskaya, I. V. Kudriavtsev, M. K. Serebriakova, A. A. Rubinstein, E. S. Kuvardin, I. N. Grigor’yeva, D. B. Aliev, D. B. Zammoeva, D. B. Motorin, A. S. Golovkin, O. V. Kalinina, S. V. Lapin, I. Z. Gaydukova, A. L. Maslyanskiy, E. K. Gaydukova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2024-03-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400961832845312
author S. S. Benevolenskaya
I. V. Kudriavtsev
M. K. Serebriakova
A. A. Rubinstein
E. S. Kuvardin
I. N. Grigor’yeva
D. B. Aliev
D. B. Zammoeva
D. B. Motorin
A. S. Golovkin
O. V. Kalinina
S. V. Lapin
I. Z. Gaydukova
A. L. Maslyanskiy
E. K. Gaydukova
author_facet S. S. Benevolenskaya
I. V. Kudriavtsev
M. K. Serebriakova
A. A. Rubinstein
E. S. Kuvardin
I. N. Grigor’yeva
D. B. Aliev
D. B. Zammoeva
D. B. Motorin
A. S. Golovkin
O. V. Kalinina
S. V. Lapin
I. Z. Gaydukova
A. L. Maslyanskiy
E. K. Gaydukova
author_sort S. S. Benevolenskaya
collection DOAJ
description Relevance. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies.The aim of the study – to compare composition of peripheral blood cytotoxic CD8+ T lymphocytes (Tc) subsets and assess the clinical significance of them in systemic lupus erythematosus. Materials and methods. A total of 35 SLE patients and 49 healthy volunteers were included in the study. Phenotyping of peripheral blood T cell subpopulations was carried out by means of flow cytometry. T lymphocytes were determined using CD3+, CD4+, CD8+ antibodies. Tc were identified by using CD45RA and CD62L antibodies. Also the expression of chemokine receptors (CCR4, CCR6, CXCR3 and CXCR5) on Tc cells was assessed and the main Tc subpopulations were determined: Type 1 (Tc1), type 2 (Tc2), type 17 (Tc17), type 17/1 (Tc17.1), type 17/22 (Tc17.22) cytotoxic cells and T follicular cytotoxic cells (Tfc).Results. The absolute and relative number of Tc was significantly higher in the group of patients with SLE compared with the control group. Additionally, there was a significant decrease in the relative number of Tc1, Tc 17.1 and Tfc1 and a significant increase in the relative number of Tc2, Tfc 17 and Tfc17.1 within the SLE group when compared to the control group. There were significant positive correlationfor Tc1 and levels of C3 and C4 complement components (r=0.404, p&lt;0.05).Conclusions. The absolute and relative number of peripheral blood Tc subsets is altered in SLE patients compared with the control group. It was found that patients with SLE contained increased number of Tc2 cells, which seems to be associated with markers of disease activity. These results demonstrate a prominent pathological role of Tc2 in SLE. While Tc1, Tc17, Tc17.1, Tfc subsets probably have regulatory functions
format Article
id doaj-art-620ec49b1c9e4f4dabb149a8ef66de1b
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2024-03-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-620ec49b1c9e4f4dabb149a8ef66de1b2025-08-20T03:37:53ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922024-03-01621909710.47360/1995-4484-2024-90-972968Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosusS. S. Benevolenskaya0I. V. Kudriavtsev1M. K. Serebriakova2A. A. Rubinstein3E. S. Kuvardin4I. N. Grigor’yeva5D. B. Aliev6D. B. Zammoeva7D. B. Motorin8A. S. Golovkin9O. V. Kalinina10S. V. Lapin11I. Z. Gaydukova12A. L. Maslyanskiy13E. K. Gaydukova14Almazov National Medical Research CentreAlmazov National Medical Research Centre; Institute of Experimental MedicineInstitute of Experimental MedicineInstitute of Experimental MedicineAlmazov National Medical Research CentreAlmazov National Medical Research CentreSaint Petersburg Clinical Rheumatology Hospital N 25Almazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentrePavlov First Saint Petersburg State Medical UniversityNorth-Western State Medical University named after I.I. MechnikovAlmazov National Medical Research Centre; Saint Petersburg State UniversitySorbonne UniversityRelevance. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies.The aim of the study – to compare composition of peripheral blood cytotoxic CD8+ T lymphocytes (Tc) subsets and assess the clinical significance of them in systemic lupus erythematosus. Materials and methods. A total of 35 SLE patients and 49 healthy volunteers were included in the study. Phenotyping of peripheral blood T cell subpopulations was carried out by means of flow cytometry. T lymphocytes were determined using CD3+, CD4+, CD8+ antibodies. Tc were identified by using CD45RA and CD62L antibodies. Also the expression of chemokine receptors (CCR4, CCR6, CXCR3 and CXCR5) on Tc cells was assessed and the main Tc subpopulations were determined: Type 1 (Tc1), type 2 (Tc2), type 17 (Tc17), type 17/1 (Tc17.1), type 17/22 (Tc17.22) cytotoxic cells and T follicular cytotoxic cells (Tfc).Results. The absolute and relative number of Tc was significantly higher in the group of patients with SLE compared with the control group. Additionally, there was a significant decrease in the relative number of Tc1, Tc 17.1 and Tfc1 and a significant increase in the relative number of Tc2, Tfc 17 and Tfc17.1 within the SLE group when compared to the control group. There were significant positive correlationfor Tc1 and levels of C3 and C4 complement components (r=0.404, p&lt;0.05).Conclusions. The absolute and relative number of peripheral blood Tc subsets is altered in SLE patients compared with the control group. It was found that patients with SLE contained increased number of Tc2 cells, which seems to be associated with markers of disease activity. These results demonstrate a prominent pathological role of Tc2 in SLE. While Tc1, Tc17, Tc17.1, Tfc subsets probably have regulatory functionshttps://rsp.mediar-press.net/rsp/article/view/3517lymphoid cell subpopulationsсd8<sup>+</sup> t cellssystemic lupus erythematosusflow cytometry
spellingShingle S. S. Benevolenskaya
I. V. Kudriavtsev
M. K. Serebriakova
A. A. Rubinstein
E. S. Kuvardin
I. N. Grigor’yeva
D. B. Aliev
D. B. Zammoeva
D. B. Motorin
A. S. Golovkin
O. V. Kalinina
S. V. Lapin
I. Z. Gaydukova
A. L. Maslyanskiy
E. K. Gaydukova
Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
Научно-практическая ревматология
lymphoid cell subpopulations
сd8<sup>+</sup> t cells
systemic lupus erythematosus
flow cytometry
title Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
title_full Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
title_fullStr Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
title_full_unstemmed Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
title_short Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
title_sort main circulating cd8 sup sup t cell subsets in patients with systemic lupus erythematosus
topic lymphoid cell subpopulations
сd8<sup>+</sup> t cells
systemic lupus erythematosus
flow cytometry
url https://rsp.mediar-press.net/rsp/article/view/3517
work_keys_str_mv AT ssbenevolenskaya maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT ivkudriavtsev maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT mkserebriakova maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT aarubinstein maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT eskuvardin maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT ingrigoryeva maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT dbaliev maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT dbzammoeva maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT dbmotorin maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT asgolovkin maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT ovkalinina maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT svlapin maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT izgaydukova maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT almaslyanskiy maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus
AT ekgaydukova maincirculatingcd8supsuptcellsubsetsinpatientswithsystemiclupuserythematosus